All News Agios Pharmaceuticals, Inc.

Equities

AGIO

US00847X1046

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
34.58 ^USD	+2.73%		+9.19%	+55.28%

May. 02	Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss	MT
May. 02	Earnings Flash (AGIO) AGIOS PHARMACEUTICALS Reports Q1 Revenue $8.2M	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss	May. 02	MT
Agios Pharmaceuticals : First Quarter 2024 Financial Results Presentation	May. 02	PU
Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024	May. 02
Agios Pharmaceuticals: Q1 Earnings Snapshot	May. 02	AQ
Earnings Flash (AGIO) AGIOS PHARMACEUTICALS Reports Q1 Revenue $8.2M	May. 02	MT
Agios Reports Business Highlights and First Quarter 2024 Financial Results	May. 02	AQ
Agios Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024	Apr. 18	AQ
Agios Publishes 2024 Environmental, Social and Governance Report	Apr. 10	AQ
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report	Apr. 09	AQ
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024	Mar. 06	AQ
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024	Mar. 05	AQ
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024	Feb. 22	AQ
RBC Trims Price Target on Agios Pharmaceuticals to $42 From $43, Keeps Outperform Rating	Feb. 16	MT
Agios Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Agios Pharmaceuticals 2023 Loss Widens, Revenue Rises	Feb. 15	MT
Transcript : Agios Pharmaceuticals, Inc., Q4 2023 Earnings Call, Feb 15, 2024	Feb. 15
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	Feb. 15	AQ
Agios Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024	Feb. 02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Agios Pharmaceuticals, Inc.

Equities

AGIO

US00847X1046

All News

Filters